Document Preview Unavailable
The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication
Iart, Luca Shytaj; Fares, Mohamed; Lucic, Bojana; Gallucci, Lara; Tolba, Mahmoud M; et al. bioRxiv, Mar 9, 2021.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library